Engaged through trade associations and directly with policymakers in all regions to address systemic barriers to access, and helping to build healthy markets where regulation and policies recognize and reward the benefits of both innovation and competition in sustaining the delivery of high-quality, affordable medicine is another key goal for our advocacy.